| 23 |
97: Alkylation, DNA |
336: Increase, Heritable mutations in offspring |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 25 |
97: Alkylation, DNA |
185: Increase, Mutations |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 67 |
55: Cell injury/death |
134: Increase, Kupffer cell activation |
Nov 29, 2016 |
Nov 29, 2016 |
6 AOPs
|
| 147 |
134: Increase, Kupffer cell activation |
276: Up Regulation, TGFbeta1 expression |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 172 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
139: N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 202 |
185: Increase, Mutations |
336: Increase, Heritable mutations in offspring |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 203 |
186: Altered, Neuroanatomy |
192: Altered, Neurophysiology |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 210 |
191: Neuronal dysfunction |
188: Neuroinflammation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 253 |
219: Reduction, Plasma 17beta-estradiol concentrations |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 269 |
244: Alkylation, Protein |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 304 |
276: Up Regulation, TGFbeta1 expression |
265: Increase, HSC activation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 342 |
376: Increased, Induced Mutations in Critical Genes |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 343 |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 345 |
373: Formation, Pro-mutagenic DNA Adducts |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 348 |
381: BDNF, Reduced |
382: Aberrant, Dendritic morphology |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 351 |
376: Increased, Induced Mutations in Critical Genes |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 352 |
373: Formation, Pro-mutagenic DNA Adducts |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 353 |
381: BDNF, Reduced |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 354 |
381: BDNF, Reduced |
383: Reduced, Presynaptic release of glutamate |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 355 |
55: Cell injury/death |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 356 |
382: Aberrant, Dendritic morphology |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 357 |
383: Reduced, Presynaptic release of glutamate |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 360 |
387: Binding of agonist, NMDARs |
388: Overactivation, NMDARs |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 362 |
389: Increased, Intracellular Calcium overload |
177: Increase, Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 363 |
177: Increase, Mitochondrial dysfunction |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
4 AOPs
|